Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 6/20 | 0.71 |
| ▸ | TGM2 | P21980 | 6/20 | 0.71 |
| ▸ | MAOA | P21397 | 6/20 | 0.55 |
| ▸ | MAOB | P27338 | 6/20 | 0.55 |
| ▸ | BCHE | P06276 | 1/20 | 0.52 |
| ▸ | S100A4 | P26447 | 1/20 | 0.50 |
| ▸ | TDP2 | O95551 | 1/20 | 0.46 |
| ▸ | KDR | P35968 | 1/20 | 0.44 |
| ▸ | CMA1 | P23946 | 1/20 | 0.44 |
| ▸ | AHR | P35869 | 1/20 | 0.44 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Nitrogen SCHEMBL29155979 | 0.96 | CES1 (0.67) | CES1TGM2MAOAMAOBBCHE | |
| SCHEMBL19931150 | 0.87 | TGM2 (0.59) | CES1TGM2MAOAMAOBS100A4 | |
| SCHEMBL11920847 | 0.83 | CES1 (0.50) | CES1TGM2MAOAMAOBS100A4 | |
| SCHEMBL16668783 | 0.83 | TGM2 (0.55) | CES1TGM2MAOAMAOBS100A4 | |
| SCHEMBL13058804 | 0.83 | TGM2 (0.55) | CES1TGM2MAOAMAOBS100A4 | |
| SCHEMBL136581 | 0.83 | TGM2 (1.00) | CES1TGM2MAOAMAOBBCHE | |
| SCHEMBL29505404 | 0.83 | TGM2 (1.00) | CES1TGM2MAOAMAOBBCHE | |
| Methane SCHEMBL28522344 | 0.82 | TGM2 (0.96) | CES1TGM2MAOAMAOBBCHE | |
| Water SCHEMBL8100148 | 0.82 | TGM2 (0.96) | CES1TGM2MAOAMAOBBCHE | |
| SCHEMBL31107465 | 0.80 | TGM2 (0.52) | CES1TGM2MAOAMAOBS100A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 735 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119798230-A | Indolone compounds and application thereof in treating acute and chronic liver diseases and promoting tissue repair | 中国药科大学 | 2025-04-11 | — | — | CN | claimed |
| CN-118978509-A | FAP receptor-targeted PET tracer and preparation method thereof | 浙江大学 | 2024-11-19 | — | — | CN | claimed |
| CN-118530159-B | Method for synthesizing 5-bromoisatin or 6-bromoisatin | 山东仁一生物科技有限责任公司 | 2024-09-20 | — | — | CN | claimed |
| CN-118530159-A | Method for synthesizing 5-bromoisatin or 6-bromoisatin | 山东仁一生物科技有限责任公司 | 2024-08-23 | — | — | CN | claimed |
| CN-111574426-B | Diamine monomer containing isoindigo structure and black polyimide synthesized by diamine monomer | 湘潭大学 | 2023-06-23 | — | — | CN | claimed |
| CN-115716795-A | Donor-acceptor type compound based on isoindigo derivative, preparation method, molecular lead and molecular electric switch | 华东理工大学 | 2023-02-28 | — | — | CN | claimed |
| CN-114805325-A | Multi-indolone Zig-Zag type bipolar small molecule and preparation method and application thereof | 湖南工程学院 | 2022-07-29 | — | — | CN | claimed |
| CN-112500341-B | Synthesis method of 7-hydroxyquinoline-4-carboxylic acid | 苏州康润医药有限公司 | 2022-04-12 | — | — | CN | claimed |
| CN-113912609-A | Preparation method of natural alkaloid tryptanthrin and derivative thereof | 江苏大学 | 2022-01-11 | — | — | CN | claimed |
| CN-112708111-A | Novel methoxyindophenine receptor and polymer, and preparation method and application thereof | 中国科学院化学研究所 | 2021-04-27 | — | — | CN | claimed |
| CN-103524511-A | Preparation method of 2,7,12-tribromo-5,10,15-trialkyltricarbazole | UNIV NANJING POSTS & TELECOMM | 2014-01-22 | — | — | CN | claimed |
| CN-102690226-A | Multi-nitrogen substituted isatin derivative and synthetic method of multi-nitrogen substituted isatin derivative | UNIV GUANGDONG TECHNOLOGY | 2012-09-26 | — | — | CN | claimed |
| CN-102351777-A | Preparation method for chiral 3-hydroxyl-3-methylene nitro indole-2-ketone derivative | UNIV SOOCHOW | 2012-02-15 | — | — | CN | claimed |
| US-20070130702-A1 | Dyeing process using a specific compound containing active methylene and a compound chosen from a specific aldehyde, a specific ketone, a quinone and a diiminoisoindoline or 3-aminoisoindolone derivative | L'OREAL S.A. | 2007-06-14 | — | — | US | claimed |
| US-7204857-B1 | Dyeing method using a specific active methylene compound and a compound selected among a specific aldehyde, a specific ketone, a quinone and a di-imino-isoindoline or 3-amino-isoindolone derivative | L'OREAL S.A. (FR) | 2007-04-17 | — | — | US | claimed |
| EP-1139989-B1 | AGENT FOR COLORING KERATINACEOUS FIBERS | HENKEL KGAA (DE) | 2006-10-18 | — | — | EP | claimed |
| US-6743263-B1 | Method for coloring keratin fibers | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2004-06-01 | — | — | US | claimed |
| US-6635090-B1 | Dyeing method using a specific cationic derivative and a compound selected among a specific aldehyde, a specific ketone, a quinone and a di-imino-isoindoline or 3-amino-isoindolone derivative | L'OREAL, S.A. (FR) | 2003-10-21 | — | — | US | claimed |
| US-6458168-B1 | Hair dyeing method using an aliphatic cationic amine and compound chosen from an aldehyde, a ketone, a quinone, a di-imino-isoindoline, and a 3-aminoisoindolone derivative | L'OREAL S.A. (FR) | 2002-10-01 | — | — | US | claimed |
| US-6451067-B1 | HAIR DYE MIXTURE | L'OREAL S.A. (FR) | 2002-09-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070130702-A1 | Dyeing process using a specific compound containing active methylene and a compound chosen from a specific aldehyde, a specific ketone, a quinone and a diiminoisoindoline or 3-aminoisoindolone derivative | KRT18, NDUFB5, NDUFB7 | CES1 3158/4885TGM2 1920/4885MAOA 467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.